The popular underground drug midomafetamine, also called MDMA and "ecstasy," failed to win an advisory panel's support as a treatment for post-traumatic stress disorder Tuesday.
FDA advisory panel votes against allowing MDMA as PTSD treatment
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться
Свежие комментарии